Mucocutaneous pemphigus vulgaris carrying high-titre antidesmoglein 1 antibodies with skin lesions resembling pemphigus erythematosus

Clinical and Experimental Dermatology

Volumn 33, Issue 1, 2008, Pages 32-35

  Cirillo, N ^a   Santoro, R ^a   Lanza, M ^a   Annese, P ^a   Gombos, F ^a   Lanza, A ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; AUTOANTIBODY; AZATHIOPRINE; DESMOGLEIN 1 ANTIBODY; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENT; PREDNISONE; STEROID;

ADULT; ANAMNESIS; ANTIBODY TITER; ARTICLE; BLOOD CHEMISTRY; CASE REPORT; CHEEK; CLINICAL EXAMINATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHEMATOUS PEMPHIGUS; FOREARM; HUMAN; IMMUNOREACTIVITY; LIP; MALE; MALE GENITAL SYSTEM; MOUTH DISEASE; PAPULE; PEMPHIGUS FOLIACEUS; PEMPHIGUS VULGARIS; PHENOTYPE; PRIORITY JOURNAL; SKIN DEFECT; STEROID THERAPY; SYSTEMIC THERAPY; THORAX; TONGUE; TOPICAL TREATMENT; WESTERN BLOTTING;

ACANTHOLYSIS; ADULT; ANIMALS; AUTOANTIBODIES; DESMOGLEIN 1; HUMANS; IMMUNOASSAY; MALE; MICE; MOUTH MUCOSA; PEMPHIGUS; PHENOTYPE; SKIN;

EID: 37349002457     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2007.02554.x     Document Type: Article

References (18)

1. Lanza A, Cirillo N, Femiano F, Gombos F. How does acantholysis occur in pemphigus vulgaris: a critical review. J Cutan Pathol 2006 33 : 401 12.
2. Stanley JR, Year M, Hawley Nelson P, Katz SI. Pemphigus antibodies identify a cell surface glycoprotein synthesized by human and mouse keratinocytes. J Clin Invest 1982 70 : 281 8.
3. Amagai M, Klaus-Kovtun V, Stanley JR. Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion. Cell 1991 67 : 869 77.
4. Bystryn JC, Rudolph JL. Pemphigus. Lancet 2005 366 : 61 73.
5. Amagai M, Tsunoda K, Zillikens D et al. The clinical phenotype of pemphigus is defined by the anti-desmoglein autoantibody profile. J Am Acad Dermatol 1999 40 : 167 70.
6. Stanley JR. Pemphigus in : Wolff K, Austen KF, Goldsmith LA, Katz S, eds. Fitzpatrick's Dermatology in General Medicine, Vol. 1. New York : McGraw-Hill, 2003 558.
7. Gomi H, Kawada A, Amagai M, Matsuo I. Pemphigus eryhtematosus: detection of anti-desmoglein 1 antibodies by ELISA. Dermatology 1999 199 : 188 9.
8. Ding X, Diaz LA, Fairley JA et al. The anti-desmoglein 1 autoantibodies in pemphigus vulgaris sera are pathogenic. J Invest Dermatol 1999 112 : 739 43.
9. Cirillo N, Gombos F, Lanza A. Changes in desmoglein 1 expression and subcellular localization in cultured keratinocytes subjected to anti-desmoglein 1 pemphigus autoimmunity. J Cell Physiol 2007 210 : 411 6.
10. Grando SA. Pemphigus in the XXI century: new life to an old story. Autoimmunity 2006 39 : 521 30.
11. Nguyen VT, Ndoye A, Shultz LD et al. Antibodies against keratinocyte antigens other than desmogleins 1 and 3 can induce pemphigus vulgaris-like lesions. J Clin Invest 2000 106 : 1467 79.
12. Cirillo N, Femiano F, Gombos F, Lanza A. Serum from pemphigus vulgaris reduces desmoglein 3 half-life and perturbs its de novo assembly to desmosomal sites in cultured keratinocytes. FEBS Lett 2006 580 : 3276 81.
13. Lanza A, Femiano F, De Rosa A et al. The N-terminal fraction of desmoglein 3 encompassing its immunodominant domain is present in human serum: implications for pemphigus vulgaris autoimmunity. Int J Immunopathol Pharmacol 2007 19 : 399 407.
14. Mahoney MG, Wang Z, Rothenberger K et al. Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris. J Clin Invest 1999 103 : 461 8.
15. Komai A, Amagai M, Ishii K et al. The clinical transition between pemphigus foliaceus and pemphigus vulgaris correlates well with the changes in autoantibody profile assessed by an enzyme-linked immunosorbent assay. Br J Dermatol 2001 144 : 1177 82.
16. Arteaga LA, Prisayanh PS, Warren SJP et al. A subset of pemphigus foliaceus patients exhibits pathogenic autoantibodies against both desmoglein-1 and desmoglein-3. J Invest Dermatol 2002 118 : 806 11.
17. Lanza A, Cirillo N. Caspase-dependent cleavage of desmoglein 1 depends on the apoptotic stimulus. Br J Dermatol 2007 156 : 400 2.
18. Cirillo N, Femiano F, Gombos F, Lanza A. Metalloproteinase 9 is the outer executioner of desmoglein 3 in apoptotic keratinocytes. Oral Dis 2007 13 : 341 5.